DebraLSudanMD

General Surgery • Durham, NC

Hepatobiliary Surgery, Pancreas, Transplantation

Professor, Surgery, Duke University School of Medicine

Join to view full profile

Dr. Sudan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sudan's full profile

Already have an account?

Office
2100 Erwin Rd
Durham, NC 27705
Phone+1 919-684-8111

Summary

Dr. Debra Sudan is a general surgeon in Durham, NC and is affiliated with Duke University Hospital. She received her medical degree from Wright State University Boonshoft School of Medicine and has been in practice 25 years. She specializes in hepatobiliary surgery and transplantation and is experienced in liver transplant surgery, intestinal failure, renal transplant surgery, general / gastrointestinal surgery, and hepatopancreatobiliary surgery.

Education & Training

University of Nebraska Medical Center College of MedicineResidency, Abdominal Transplant Surgery, 1994 - 1996
Wright State UniversityResidency, Surgery, 1989 - 1994
Wright State University Boonshoft School of MedicineClass of 1989

Certifications & Licensure

NC State Medical License 2008 - 2025
OH State Medical License 1991 - 1996
American Board of Surgery Surgery
ASTS certification in Liver, Kidney, Pancreas and Intestine transplantationASTS Transplant Surgery Certification

Awards, Honors, & Recognition

Fellow (FACS) American College of Surgeons

Clinical Trials

WP01 - Normothermic Liver Preservation Start of enrollment: 2016 Oct 09
Completed
Not Applicable
Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients Start of enrollment: 2017 May 22
Completed
Phase 2
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients Start of enrollment: 2018 Nov 28
Completed
Phase 2
WP02 Continued Access Study Start of enrollment: 2021 Oct 10
Terminated
Not Applicable
Roles: Contact
Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure Start of enrollment: 2020 Feb 27
Recruiting
Roles: Contact, Principal Investigator
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation Start of enrollment: 2023 Dec 07
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Risk Factors for Invasive Surgical Site Infections Among Adult Single Liver Transplant Recipients at Duke University Hospital in the Period 2015-2020.
Manuela Carugati, Sana Arif, Michael E Yarrington, Lindsay Y King, Matt Harris
Transplantation Direct. 2024-12-01
Hepatic Resection as the Primary Treatment Method for Hepatocellular Carcinoma After Orthotopic Liver Transplantation.
Abraham J Matar, Kailey M Oppat, Frances J Bennett, Emilie A K Warren, Chase J Wehrle
Annals of Surgical Oncology. 2024-12-01
ASO Author Reflections: Hepatic Resection as the Primary Treatment Modality for Hepatocellular Carcinoma After Orthotopic Liver Transplantation.
Abraham J Matar, Kailey M Oppat, Frances J Bennett, Emilie A K Warren, Chase J Wehrle
Annals of Surgical Oncology. 2024-12-01

Journal Articles

Small Bowel Transplantation
Debra Sudan, MD, ScienceDirect

Press Mentions

Liver Transplant Cures Rare HEHE Liver TumorApril 19th, 2019

Professional Memberships

American College of Surgeons - ACS
Member